Progress made in the therapeutic care of rheumatoid arthritis now means that the disease can be controlled more effectively and it is possible to consider a sustainable remission.
To assist the doctor and the patient in achieving the ultimate goal of disease remission, mYXpression has developed RITI® RA, a test that identifies the most efficient biologic therapy for the patient based on their biology.
RITI® RA provides the patient and their doctor with access to a personalized analysis report. This report delivers an efficacy score for each biologic therapy.
The RITI® RA test offers real precision medicine and is a valuable aid in optimizing the therapeutic strategy to adopt:
“The right treatment, for the right patient at the right time."
RITI® RA is currently undergoing clinical trials and will be available by 2025.
Find out more